XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Non-Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Shares
Beginning balance at Jan. 30, 2021 $ 566,759 $ 1,009 $ 15,438 $ 282,308 $ 320,920 $ (35,059) $ (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 8,878       8,878    
Other comprehensive income (loss) 1,458         1,458  
Share-based compensation expense 1,912     1,912      
Other 1 (181) 6 176      
Ending balance at May. 01, 2021 579,008 828 15,444 284,396 329,798 (33,601) (17,857)
Beginning balance at Jan. 30, 2021 566,759 1,009 15,438 282,308 320,920 (35,059) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 52,710            
Other comprehensive income (loss) 1,182            
Shares repurchased (30,600)            
Ending balance at Oct. 30, 2021 592,424 827 15,071 288,813 339,447 (33,877) (17,857)
Beginning balance at May. 01, 2021 579,008 828 15,444 284,396 329,798 (33,601) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 10,937       10,937    
Other comprehensive income (loss) 173         173  
Share-based compensation expense 2,055     2,055      
Restricted stock issuance     219 (219)      
Restricted shares withheld for taxes (4,076)   (64) 64 (4,076)    
Other     (2) 2      
Ending balance at Jul. 31, 2021 588,097 828 15,597 286,298 336,659 (33,428) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 32,895       32,895    
Other comprehensive income (loss) (449)         (449)  
Share-based compensation expense 2,509     2,509      
Shares repurchased (30,629)   (522)   (30,107)    
Other 1 (1) (4) 6      
Ending balance at Oct. 30, 2021 592,424 827 15,071 288,813 339,447 (33,877) (17,857)
Beginning balance at Jan. 29, 2022 602,468 827 14,256 291,444 350,206 (36,408) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 4,947       4,947    
Other comprehensive income (loss) (3,817)         (3,817)  
Share-based compensation expense 3,239     3,239      
Restricted stock issuance     78 (78)      
Shares repurchased (6,500)   (104)   (6,396)    
Other 1 (9) (13) 23      
Ending balance at Apr. 30, 2022 600,338 818 14,217 294,628 348,757 (40,225) (17,857)
Beginning balance at Jan. 29, 2022 602,468 827 14,256 291,444 350,206 (36,408) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 32,966            
Other comprehensive income (loss) (9,923)            
Shares repurchased (72,700)            
Ending balance at Oct. 29, 2022 559,343 817 13,101 301,692 307,921 (46,331) (17,857)
Beginning balance at Apr. 30, 2022 600,338 818 14,217 294,628 348,757 (40,225) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 7,643       7,643    
Other comprehensive income (loss) (1,699)         (1,699)  
Share-based compensation expense 3,549     3,549      
Restricted stock issuance     239 (239)      
Restricted shares withheld for taxes (3,875)   (72) 72 (3,875)    
Shares repurchased (45,422)   (826)   (44,596)    
Other (1)   (1)        
Ending balance at Jul. 30, 2022 560,533 818 13,557 298,010 307,929 (41,924) (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 20,376       20,376    
Other comprehensive income (loss) (4,407)         (4,407)  
Share-based compensation expense 3,676     3,676      
Restricted shares withheld for taxes (67)   (2) 2 (67)    
Shares repurchased (20,768)   (451)   (20,317)    
Other   (1) (3) 4      
Ending balance at Oct. 29, 2022 $ 559,343 $ 817 $ 13,101 $ 301,692 $ 307,921 $ (46,331) $ (17,857)